Literature DB >> 8753692

The effect of steroid on thallium-201 uptake by malignant gliomas.

H Namba1, T Togawa, N Yui, M Yanagisawa, F Kinoshita, Y Iwadate, K Ohsato, K Sueyoshi.   

Abstract

In order to assess the effect of steroid on thallium-201 uptake by glioma, 201Tl single-photon emission tomography was performed before and after steroid administration in four patients with recurrent malignant glioma. After steroid administration the 201Tl index, expressed as the ratio of 201Tl uptake in the tumour to that in the contralateral cerebral hemisphere, was 0.77+/-0.11 of the value before steroid (mean+/-SD: P<0.05 by paired t test). The 201Tl index has been used as a possible indicator for the differentiation of malignant gliomas from relatively benign tumours or radiation necrosis. The present results indicate that the effect of steroid has to be taken into account when semi-quantitative analysis, e.g. by means of the 201Tl index, is used in patients with brain tumours.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8753692     DOI： 10.1007/bf01084377

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  10 in total

1.  The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82Rb: a positron emission tomographic study.

Authors:  J O Jarden; V Dhawan; J R Moeller; S C Strother; D A Rottenberg
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

2.  Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells.

Authors:  T Brismar; V P Collins; M Kesselberg
Journal:  Brain Res       Date:  1989-10-23       Impact factor: 3.252

3.  Use of thallium-201 SPECT to quantitate malignancy grade of gliomas.

Authors:  K L Black; R A Hawkins; K T Kim; D P Becker; C Lerner; D Marciano
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

4.  Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors.

Authors:  S Kosuda; H Fujii; S Aoki; K Suzuki; Y Tanaka; O Nakamura; N Shidara
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

5.  Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme.

Authors:  F T Vertosick; R G Selker; S J Grossman; J M Joyce
Journal:  Neurosurgery       Date:  1994-03       Impact factor: 4.654

6.  Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.

Authors:  P A Carvalho; R B Schwartz; E Alexander; B M Garada; R E Zimmerman; J S Loeffler; B L Holman
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

7.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

Authors:  G Di Chiro; R L DeLaPaz; R A Brooks; L Sokoloff; P L Kornblith; B H Smith; N J Patronas; C V Kufta; R M Kessler; G S Johnston; R G Manning; A P Wolf
Journal:  Neurology       Date:  1982-12       Impact factor: 9.910

8.  Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities.

Authors:  N Oriuchi; M Tamura; T Shibazaki; C Ohye; N Watanabe; M Tateno; K Tomiyoshi; T Hirano; T Inoue; K Endo
Journal:  J Nucl Med       Date:  1993-12       Impact factor: 10.057

9.  Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.

Authors:  K Ericson; A Lilja; M Bergström; V P Collins; L Eriksson; E Ehrin; H von Holst; H Lundqvist; B Långsrom B; M Mosskin
Journal:  J Comput Assist Tomogr       Date:  1985 Jul-Aug       Impact factor: 1.826

10.  Time sequential single photon emission computed tomography studies in brain tumour using thallium-201.

Authors:  T Ueda; Y Kaji; S Wakisaka; K Watanabe; H Hoshi; S Jinnouchi; S Futami
Journal:  Eur J Nucl Med       Date:  1993-02
  10 in total
  3 in total

1.  201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas.

Authors:  K Kallén; I M Burtscher; S Holtås; E Ryding; I Rosén
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.

Authors:  V Vallejos; C Balaña; M Fraile; Y Roussos; J Capellades; P Cuadras; R Ballester; A Ley; A Arellano; R Rosell
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

Review 3.  The role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.

Authors:  Timothy Charles Ryken; Nafi Aygun; Johnathan Morris; Marin Schweizer; Rajeshwari Nair; Cassandra Spracklen; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2014-04-09       Impact factor: 4.130
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.